Dynamics of HCV epidemiology among HIV plus patients in Vienna

被引：1
|
作者：
Schmidbauer, Caroline [1 ,2 ,3 ]
Chromy, David [1 ,2 ]
Bauer, David [1 ,2 ]
Schmidbauer, Victor [1 ,2 ]
Mandorfer, Mattias [1 ,2 ]
Rieger, Armin [4 ]
Mayer, Florian [5 ]
Holzmann, Heidemarie [6 ]
Trauner, Michael [2 ]
Gschwantler, Michael [3 ]
Reiberger, Thomas [1 ,2 ]
机构：
[1] Vienna HIV & Liver Study Grp, Vienna, Austria
[2] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria
[3] Wilhelminenspital Stadt Wien, Wiener Krankenanstaltenverbund, Dept Internal Med 4, Vienna, Austria
[4] Med Univ Vienna, Dept Dermatol, Vienna, Austria
[5] Med Univ Vienna, Div Virol, Dept Lab Med, Vienna, Austria
[6] Med Univ Vienna, Ctr Virol, Vienna, Austria
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)31000-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-255
引用
收藏
页码：E506 / E507
页数：2
相关论文
共 50 条
  • [41] Epidermoid anal cancer prognosis comparison among HIV plus and HIV- patients
    Abramowitz, L.
    Mathieu, N.
    Roudot-Thoraval, F.
    Lemarchand, N.
    Bauer, P.
    Hennequin, C.
    Mitry, E.
    Romelaer, C.
    Aparicio, T.
    Sobhani, I.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (04) : 414 - 421
  • [42] MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients
    Moghoofei, Mohsen
    Najafipour, Sohrab
    Mostafaei, Shayan
    Tavakoli, Ahmad
    Bokharaei-Salim, Farah
    Ghorbani, Saied
    Javanmard, Davod
    Ghaffari, Hadi
    Monavari, Seyed Hamidreza
    CURRENT HIV RESEARCH, 2021, 19 (01) : 27 - 34
  • [43] Immunereconstitution among HIV patients treated with HAART and receiving anti HCV treatment
    Meschiari, M.
    Franceschini, E.
    Bisi, L.
    Manzini, L.
    Esposito, R.
    Mussini, C.
    Borghi, V.
    INFECTION, 2010, 38 : 82 - 83
  • [44] Distribution of HCV genotypes among patients co-infected with HIV in Brazil
    Mendes-Corrêa, MCJ
    Cavalheiro, N
    Barone, AA
    ANTIVIRAL THERAPY, 2002, 7 (04) : L129 - L129
  • [45] Pharmacokinetics (PK) of protease inhibitors (PIS) in HIV+/HCV plus patients without cirrhosis
    Regazzi, MB
    Villani, P
    Micheli, V
    Cusato, M
    Zucchi, P
    Meraviglia, P
    Maserati, M
    Cargnel, A
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 240 - 241
  • [46] Comorbidities and HCV coinfection in the management of HIV plus patients: evidence from the Italian clinical practice
    Garagiola, Elisabetta
    Foglia, Emanuela
    Ferrario, Lucrezia
    Meraviglia, Paola
    Tebini, Alessandro
    Menzaghi, Barbara
    Atzori, Chiara
    Rizzardini, Giuliano
    Bini, Teresa
    Monforte, Antonella D'Arminio
    Croce, Davide
    HEALTH ECONOMICS REVIEW, 2020, 10 (01)
  • [47] HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan
    Huang, Miao-Hui
    Chang, Sui-Yuan
    Liu, Chen-Hua
    Cheng, Aristine
    Su, Li-Hsin
    Liu, Wen-Chun
    Su, Yi-Ching
    Sun, Hsin-Yun
    Hung, Chien-Ching
    Chang, Shan-Chwen
    LIVER INTERNATIONAL, 2019, 39 (10) : 1860 - 1867
  • [48] Motor Disinhibition Is More Common Among Neuropsychologically Impaired HCV plus Persons than Comparable HIV plus Individuals or Methamphetamine Abusers
    Moore, David J.
    Vigil, Ofilio
    Vaida, Florin
    Grant, Igor
    Caligiuri, Michael
    JOURNAL OF NEUROVIROLOGY, 2009, 15 : 63 - 63
  • [49] Epidemiology of obesity among people with HIV
    Talathi, Ria
    Anekwe, Chika V.
    Toribio, Mabel
    CURRENT OPINION IN HIV AND AIDS, 2024, 19 (01) : 1 - 5
  • [50] HCV genotypes and age distribution in patients of Vienna and surrounding areas
    Haushofer, AC
    Kopty, C
    Hauer, R
    Brunner, H
    Halbmayer, WM
    JOURNAL OF CLINICAL VIROLOGY, 2001, 20 (1-2) : 41 - 47
12345